Idiopathic Pulmonary Fibrosis

Showing 26 - 50 of 350

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement Trial in El Paso (Vixarelimab, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Systemic Sclerosis With Lung Involvement
  • El Paso, Texas
    El Paso Pulmonary Association Elligo PPDS
Mar 14, 2023

Radiomics Algorithm for UIP Compared to Medical Doctors

Completed
  • Idiopathic Pulmonary Fibrosis
  • +2 more
  • Radiomics model to classify between IPF with UIP pattern and ILDs without UIP pattern
  • Maastricht, Limburg, Netherlands
    Maastricht University
Mar 14, 2023

Idiopathic Pulmonary Fibrosis Trial in Rome (Autologous FMT, Placebo FMT)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Autologous FMT
  • Placebo FMT
  • Rome, Roma, Italy
    Fondazione Policlinico Agostino Gemelli IRCCS
Feb 23, 2023

Idiopathic Pulmonary Fibrosis Trial (SHR-1906, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Feb 1, 2023

Idiopathic Pulmonary Fibrosis Trial (Ifetroban Sodium, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ifetroban Sodium
  • Placebo
  • (no location specified)
Jan 25, 2023

Idiopathic Pulmonary Fibrosis Trial (BI 1015550, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • BI 1015550
  • Placebo
  • New Haven, Connecticut
  • +134 more
Jan 23, 2023

All-Case Surveillance of Ofev in Patients With IPF in Japan

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Multiple Locations, Japan
    (unnamed)
Jan 23, 2023

Idiopathic Pulmonary Fibrosis Trial in Worldwide (PRM-151 (Zinpentraxin Alfa), Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • PRM-151 (Zinpentraxin Alfa)
  • Placebo
  • Birmingham, Alabama
  • +407 more
Jan 19, 2023

Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Interstitial Pneumonitis Trial in Bethesda, Falls Church (Aerobic

Recruiting
  • Interstitial Lung Disease
  • +3 more
  • Aerobic Exercise Training (AET)
  • No AET (education only)
  • Bethesda, Maryland
  • +1 more
Jan 18, 2023

Idiopathic Pulmonary Fibrosis Trial in United States (N-acetyl cysteine, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • N-acetyl cysteine
  • Placebo
  • Tucson, Arizona
  • +24 more
Jan 14, 2023

Under Routine Clinical Practice in Taiwan to Observe Long-term

Active, not recruiting
  • Idiopathic Pulmonary Fibrosis
  • Changhua, Taiwan
  • +26 more
Jan 9, 2023

Idiopathic Pulmonary Fibrosis Trial (TTI-101, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Jan 3, 2023

Idiopathic Pulmonary Fibrosis Trial in Worldwide (C21)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ahmedabad, Gujarat, India
  • +23 more
Jan 2, 2023

Idiopathic Pulmonary Fibrosis Trial in Brooklyn (AZD5055, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Brooklyn, Maryland
    Research Site
Dec 22, 2022

Idiopathic Pulmonary Fibrosis Trial in United States (Placebo, Pirfenidone, Deupirfenidone)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +39 more
Dec 20, 2022

Idiopathic Pulmonary Fibrosis Trial in Beijing, Guangzhou, Shanghai (REGEND001 Autologous Therapy Product)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • REGEND001 Autologous Therapy Product
  • Beijing, Beijing, China
  • +2 more
Dec 19, 2022

Idiopathic Pulmonary Fibrosis Trial in Worldwide (PRM-151 (Zinpentraxin Alfa))

Active, not recruiting
  • Idiopathic Pulmonary Fibrosis
  • PRM-151 (Zinpentraxin Alfa)
  • Birmingham, Alabama
  • +241 more
Dec 16, 2022

Idiopathic Pulmonary Fibrosis Trial in Tours (intrapulmonary percussive ventilation, delivery of 99mTc-DTPA aerosol)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • intrapulmonary percussive ventilation
  • delivery of 99mTc-DTPA aerosol
  • Tours, France
    Pulmonology Department, University Hospital, Tours
Dec 7, 2022

Idiopathic Pulmonary Fibrosis Trial in Boston (PLN-74809, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 14, 2022

Idiopathic Pulmonary Fibrosis Trial in Palo Alto (PLN-74809, Knottin tracer)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Palo Alto, California
    Stanford Medical Center
Nov 15, 2022

Idiopathic Pulmonary Fibrosis Trial in Worldwide (ND-L02-s0201, Other: Placebo)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Tucson, Arizona
  • +32 more
Nov 15, 2022

Idiopathic Pulmonary Fibrosis, IPF Trial in Izmir (Inspiratory Muscle Training (IMT), Sham IMT)

Completed
  • Idiopathic Pulmonary Fibrosis
  • IPF
  • Inspiratory Muscle Training (IMT)
  • Sham IMT
  • Izmir, Balcova, Turkey
    Dokuz Eylul University
Nov 6, 2022

Interstitial Lung Disease, Sarcoidosis, Idiopathic Pulmonary Fibrosis Trial in Kansas City

Recruiting
  • Interstitial Lung Disease
  • +4 more
    • Kansas City, Kansas
      The University of Kansas Medical Center
    Nov 5, 2022

    Respiratory Muscle Strength in Idiopathic Pulmonary Fibrosis

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • no intervention - cross-sectional observational only
    • Istanbul, Zeytinburnu, Turkey
      Yedikule Chest Disease Hospital
    Nov 4, 2022

    Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis Trial (Hyperoxia)

    Not yet recruiting
    • Interstitial Lung Disease
    • +4 more
    • Hyperoxia
    • (no location specified)
    Nov 1, 2022